Quality Metrics & Ratings
Expert articles and analysis related to quality metrics & ratings.
AI Summary — Last 24 Hours
Quality-measure pressure is showing up less through new CMS rulemaking and more through payer/provider operating models: Pyx Health is positioning food-based engagement as a way for plans to improve quality metrics and strengthen payer partnerships, signaling continued demand for vendors that can tie social-needs interventions to Star Ratings, HEDIS, and retention outcomes (TipRanks). In oncology and cardiovascular care, reports on community oncology survival
Related Articles
Pyx Health Leverages Food-Based Engagement and Quality Metrics to Strengthen Payer Partnerships
Pyx Health Leverages Food-Based Engagement and Quality Metrics to Strengthen Payer Partnerships TipRanks
The Trouble With Cancer Screening In Healthy Adults – OpEd
The Trouble With Cancer Screening In Healthy Adults – OpEd Eurasia Review
[Perspectives] The unfinished path towards patient safety
To submit your body to surgery is to commit a peculiar act of faith. You consent to being rendered unconscious and placed entirely in the hands of someone you have usually met only a few times. The ex...
How anchoring bias in medicine missed a heart attack
How anchoring bias in medicine missed a heart attack KevinMD.com
Prognostic associations of the G8 geriatric screening tool in the EORTC Brain Tumor Group trials 1608 and 1709 in patients with newly diagnosed glioblastoma.
Prognostic associations of the G8 geriatric screening tool in the EORTC Brain Tumor Group trials 1608 and 1709 in patients with newly diagnosed glioblastoma. American Society of Clinical Oncology - A...
Predicting pathologic complete response (pCR) from clinicopathologic variables and HER2DX genomic test in stage II/III HER2+ breast cancer treated with taxane, trastuzumab, and pertuzumab (THP): Secondary results from the EA1181/CompassHER2 pCR t
Predicting pathologic complete response (pCR) from clinicopathologic variables and HER2DX genomic test in stage II/III HER2+ breast cancer treated with taxane, trastuzumab, and pertuzumab (THP): Secon...
Dr. Cykert on the system that nearly ended cancer care disparities
Dr. Cykert on the system that nearly ended cancer care disparities Rolling Out
Neoadjuvant therapy for rectal cancer: Mature results from NSABP protocol R-04.
Neoadjuvant therapy for rectal cancer: Mature results from NSABP protocol R-04. American Society of Clinical Oncology - ASCO
Why Pharmacists Are the New Frontline in Identifying Hypercortisolism
Is Endovascular Treatment Effective in Patients with Large Ischemic Stroke?
Is Endovascular Treatment Effective in Patients with Large Ischemic Stroke? NEJM Clinician